Drug Development Process | Drug Approval

Stay on the cutting edge of major market events in drug development. Powered by real-time intelligence, Biomedtracker’s web-based platform tracks and analyzes clinical and regulatory developments so you can quickly and accurately assess a drug's probability of technical success.

How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.

How it works
Biomedtracker’s intuitive interface features the latest, industry-acclaimed insights, all at your fingertips. We track impactful future catalysts, and then analyze these commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface that keeps you at the top of your game.

Our analysts attend the medical and investor meetings that matter to you, bringing you not just the news, but vital information on how it impacts your bottom line.

Learn more about the next generation of Biomedtracker

Request a demo

Biomedtracker, Meddevicetracker

Q4 2019 Outlook Report Extract

16 Oct 2019

What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.

Biomedtracker

Q3 2019 Catalyst Roundup

16 Oct 2019

What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.

Biomedtracker, Datamonitor Healthcare

Key potential drug launches 2020

27 Sep 2019

Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.

Biomedtracker

Biomedtracker: Improved Custom Company Portfolio Feature

04 Sep 2019

Discover how creating custom company portfolios can help you overcome your toughest business challenges.

Biomedtracker

Biomedtracker Q3 2019 Outlook Report Extract

29 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

Datamonitor Healthcare, Biomedtracker, Pharmapremia

2019 Q3 Outlook Webinar

By Hardik Patel 15 Jul 2019

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.

Meddevicetracker, Biomedtracker

When Part of the Picture Isn't Enough

05 Jul 2019

Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and diﬃcult to ﬁnd, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your ﬁngertips, saving you time and eﬀort. The new “Associated Products” section on relevant Biomedtracker Drug Proﬁle pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.

Datamonitor Healthcare, Biomedtracker

Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

By Michael Haydock 02 Jul 2019

Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

Biomedtracker

Biomedtracker: Catalyst Roundup 2018 Q4

02 Jul 2019

A Review of Select Catalysts from Last Quarter’s Outlook Report.

Meddevicetracker, Biomedtracker

Q2 2019 Outlook Report

03 May 2019

In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Biomedtracker, Datamonitor Healthcare

December 2018 National Influenza Week

10 Apr 2019

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Biomedtracker

Biomedtracker 2018 Early Outlook Report

10 Apr 2019

What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Biomedtracker, Meddevicetracker

Biomedtracker: Early 2019 Outlook Report Extract

10 Apr 2019

In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

Biomedtracker

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

By Dominique Fontanilla 19 Nov 2018

Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

Biomedtracker

Biomedtracker Q4 2018 Outlook Report

19 Oct 2018

Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

Tracking drug development

What's included

Below are the Feature List

Stay up to date

Get ahead of the competition

Conference coverage

Forecast your market’s future

Leverage analysts’ knowledge

Pharma Intelligence: latest

Q4 2019 Outlook Report Extract

Q3 2019 Catalyst Roundup

Key potential drug launches 2020

Biomedtracker: Improved Custom Company Portfolio Feature

Biomedtracker Q3 2019 Outlook Report Extract

2019 Q3 Outlook Webinar

When Part of the Picture Isn't Enough

Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

Biomedtracker: Catalyst Roundup 2018 Q4

Q2 2019 Outlook Report

December 2018 National Influenza Week

Biomedtracker 2018 Early Outlook Report

Biomedtracker: Early 2019 Outlook Report Extract

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

Biomedtracker Q4 2018 Outlook Report

Meet the team

Below are the Analyst Profile

Patricia Reilly

Management, VP, Intelligence Alliances and Product Unification

Gail Parziale

Management, Head of Intelligence Editorial Operations

Rachel Meighan-Mantha

Analyst, Principal Analyst

Datamonitor Healthcare: data analysis and insight

Trialtrove: gold standard clinical trials intelligence

Medtrack: full healthcare business coverage

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Pharma Report Store

Biomedtracker: follow the drug development process

Tracking drug development

What's included

Below are the Feature List

Stay up to date

Get ahead of the competition

Conference coverage

Forecast your market’s future

Leverage analysts’ knowledge

Pharma Intelligence: latest

Meet the team

Below are the Analyst Profile

Patricia Reilly

Management, VP, Intelligence Alliances and Product Unification

Gail Parziale

Management, ​Head of Intelligence Editorial Operations

Rachel Meighan-Mantha

Analyst, Principal Analyst

Related Products

Datamonitor Healthcare: data analysis and insight

Trialtrove: gold standard clinical trials intelligence

Medtrack: full healthcare business coverage

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Pharma Report Store

Management, Head of Intelligence Editorial Operations